Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 53 citing Cook: Glycemic control continues to deteriorate after sulfonylureas are added to metformin.... (0.11 sec) 

Comparison between vildagliptin and metformin to sustain reductions in HbA1c …


A Schweizer, A Couturier, JE Foley, S … - Diabetic Medicine, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 90 - Related articles - BL Direct - All 4 versions

An open, randomized, parallel-group study to compare the efficacy and safety …

- diabetesjournals.org
AH Barnett, M Dreyer, P Lange, M Serdarevic- … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—Mean adjusted A1C changes from baseline were –2.03 and –1.88% in the INH and
glibenclamide groups, respectively; between-treatment difference –0.17% (95% CI –0.34 to
0.01; P = 0.058), consistent with the noninferiority criterion. In the A1C >9.5% arm, inhaled ...
Cited by 47 - Related articles - BL Direct - All 8 versions

Progress in the treatment of type 2 diabetes: new pharmacologic approaches to …


A Cohen, ES Horton - Current Medical Research and Opinion®, 2007 - informahealthcare.com
Background: Type 2 diabetes mellitus (T2DM) is a leading cause of morbidity and mortality that
places a substantial economic and health burden on the public. Successful management of T2DM
requires strict control of glycemia as well as other risk factors to prevent disease ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Treatment escalation and rise in HbA1c following successful initial metformin …


GA Nichols, CM Alexander, CJ Girman, SJ Kamal-Bahl, … - Diabetes care, 2006 - ncbi.nlm.nih.gov
OBJECTIVE: To describe secondary failure of initial metformin therapy in patients who achieved
initial HbA(1c) (A1C) <8% and to identify predictors of failure. RESEARCH DESIGN AND
METHODS: We identified 1,288 patients who achieved A1C <8% within 1 year of initiating ...
Cited by 25 - Related articles - BL Direct - All 4 versions

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study …


RR Holman - Metabolism, 2006 - Elsevier
The United Kingdom Prospective Diabetes Study shows sulfonylureas to be an effective
first-line therapy for people with type 2 diabetes mellitus. The durability of the glycemic control
obtained is dependent on the degree to which beta-cell function can be maintained, but ...
Cited by 19 - Related articles - All 11 versions

Nateglinide-current and future role in the treatment of patients with type 2 diabetes …


IW Campbell - International Journal of Clinical Practice, 2005 - medscape.com
Therapy for type 2 diabetes mellitus should aim to control not only fasting, but also postprandial
glucose levels. Nateglinide, a d-phenylalanine derivative, restores postprandial early phase
insulin secretion in a transient and glucose-sensitive manner without affecting basal ...
Cited by 15 - Related articles - BL Direct - All 6 versions

Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long- …


LB Haas - Journal of the American Medical Directors Association, 2007 - Elsevier
Approximately 25% of patients in nursing homes have diabetes, and it is the primary reason
for 12% of nursing home admissions among residents 45 to 75 years of age. Glycemic control
is important to reduce the risk of diabetic complications in this patient population. ...
Cited by 14 - Related articles - All 12 versions

Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin …


MJ Calvert, RJ McManus, N … - The British Journal of …, 2007 - pubmedcentral.nih.gov
To examine the extent of monitoring and glycaemic control of patients with type 2 diabetes prescribed
oral agents and/or insulin, and to investigate transition to insulin. ... A total of 154 general practices
in the UK contributing to the DIN-LINK database between 1995 and 2005.
Cited by 12 - Related articles - BL Direct - All 5 versions

Loss of glycemic control in patients with type 2 diabetes mellitus who were …


AA Riedel, H Heien, J Wogen, CA Plauschinat - Pharmacotherapy, 2007 - PPI
Aylin A. Riedel, Ph.D., Herbert Heien, MS, Jenifer Wogen, MS, and Craig A. Plauschinat,
Pharm.D., MPH ... Study Objectives. To examine glycosylated hemoglobin (A1C) values longitudinally
in patients who newly started metformin, sulfonylurea, or thiazolidinedione monotherapy; ...
Cited by 12 - Related articles - BL Direct - All 3 versions

Advancing therapy in type 2 diabetes mellitus with early, comprehensive …

- clinicaltherapeutics.com [PDF] 
A Vinik - Clinical therapeutics, 2007 - Elsevier
Methods: Relevant English-language articles published from 1996 to 2006 were identified through
searches of the National Center for Biotechnology PubMed database. Search terms included
insulin, insulin therapy, type 2 diabetes, insulin analogs, early insulinization, and diabetes ...
Cited by 13 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google